Phase 1 Trial of Engineered HSV G207 in Children with Malignant Cerebellar Brain Tumors

Grant

Date/time Interval

  • July 1, 2019 - June 30, 2022
  • Total Award Amount

  • 66600.00
  • Direct Costs

  • 66600.00
  • Sponsor Award Id

  • Contributor

  • Aban, Inmaculada   Investigator  
  • Fiveash M.D., John   Investigator  
  • Friedman M.D., Gregory   Principal Investigator  
  • Johnston, James   Investigator  
  • Markert M.D., M.P.H., James   Investigator